Literature DB >> 17436015

Osteoporosis in juvenile idiopathic arthritis--a practical approach to diagnosis and therapy.

Johannes Roth1, Susanne Bechtold, Gudrun Borte, Frank Dressler, Hermann J Girschick, Michael Borte.   

Abstract

In all subgroups of juvenile idiopathic arthritis, a decrease in bone mass has been described in a high percentage of children. Recently, new pathogenetic concepts have identified muscle mass as the strongest predictor of bone mass and bone is now recognized as part of the musculoskeletal system. In addition, the sophisticated use of bone densitometry in pediatrics, including new measurement techniques, has provided the tools for a reliable assessment. A standardized diagnostic approach to the musculoskeletal system, including prophylaxis and therapy, is, therefore, mandatory in all children with JIA who do not achieve rapid remission. In this review, diagnostic and therapeutic options are being described and possibilities to incorporate them into clinical practice are suggested.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436015     DOI: 10.1007/s00431-007-0484-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  46 in total

Review 1.  The "muscle-bone unit" in children and adolescents: a 2000 overview.

Authors:  H M Frost; E Schönau
Journal:  J Pediatr Endocrinol Metab       Date:  2000-06       Impact factor: 1.634

2.  Therapy and prophylaxis of corticosteroid induced osteoporosis.

Authors:  P N Sambrook
Journal:  Z Rheumatol       Date:  2001-04       Impact factor: 1.372

3.  Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Nicolino Ruperto; Edward Giannini
Journal:  J Rheumatol       Date:  2004-11       Impact factor: 4.666

Review 4.  Markers of bone and collagen metabolism-problems and perspectives in paediatrics.

Authors:  E Schönau; F Rauch
Journal:  Horm Res       Date:  1997

5.  Bone mass change during methotrexate treatment in patients with juvenile rheumatoid arthritis.

Authors:  M L Bianchi; R Cimaz; E Galbiati; F Corona; R Cherubini; M Bardare
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

6.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

Review 7.  Osteoporosis in childhood rheumatic diseases: prevention and therapy.

Authors:  Rolando Cimaz
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-07       Impact factor: 4.098

Review 8.  Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis.

Authors:  J Thornton; D M Ashcroft; M Z Mughal; R A Elliott; T W O'Neill; D Symmons
Journal:  Arch Dis Child       Date:  2006-05-11       Impact factor: 3.791

Review 9.  Osteogenesis imperfecta.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

Review 10.  The role of bisphosphonates in diseases of childhood.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Eur J Pediatr       Date:  2003-09-11       Impact factor: 3.183

View more
  10 in total

1.  Assessment of bone remodelling in childhood-onset systemic lupus erythematosus.

Authors:  Julie C Baker-LePain; Mary C Nakamura; John Shepherd; Emily von Scheven
Journal:  Rheumatology (Oxford)       Date:  2010-11-23       Impact factor: 7.580

Review 2.  Juvenile idiopathic arthritis: clinically relevant imaging in diagnosis and monitoring.

Authors:  Tauny Southwood
Journal:  Pediatr Radiol       Date:  2008-06

Review 3.  Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.

Authors:  Susanne Bechtold; Dominique Simon
Journal:  Rheumatol Int       Date:  2014-04-24       Impact factor: 2.631

Review 4.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

5.  PKU patients on a relaxed diet may be at risk for micronutrient deficiencies.

Authors:  C Rohde; A von Teeffelen-Heithoff; A G Thiele; M Arelin; U Mütze; C Kiener; J Gerloff; C Baerwald; S Schultz; C Heller; A S Müller; W Kiess; S Beblo
Journal:  Eur J Clin Nutr       Date:  2013-11-20       Impact factor: 4.016

Review 6.  Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management.

Authors:  Francesca Di Marcello; Giulia Di Donato; Debora Mariarita d'Angelo; Luciana Breda; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

7.  Nutritional supplementation and dietary restriction in the resolution of enthesitis-related arthritis.

Authors:  Stephen J Genuis; Anna-Kristen J Siy
Journal:  JRSM Short Rep       Date:  2011-04-18

8.  Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone-mass determinants by using dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography.

Authors:  Stefano Stagi; Loredana Cavalli; Carla Signorini; Federico Bertini; Marco Matucci Cerinic; Maria Luisa Brandi; Fernanda Falcini
Journal:  Arthritis Res Ther       Date:  2014-03-31       Impact factor: 5.156

Review 9.  A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology.

Authors:  S Bobo Tanner; Charles F Moore
Journal:  Open Access Rheumatol       Date:  2012-12-11

10.  A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.

Authors:  Arzu Soybilgic; Melissa Tesher; Linda Wagner-Weiner; Karen B Onel
Journal:  Pediatr Rheumatol Online J       Date:  2014-07-09       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.